127 related articles for article (PubMed ID: 34043770)
21. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
[TBL] [Abstract][Full Text] [Related]
22. Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
Lo SN; Ma J; Scolyer RA; Haydu LE; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Ch'ng S; Mann GJ; Gershenwald JE; Thompson JF; Varey AHR
J Clin Oncol; 2020 Aug; 38(24):2719-2727. PubMed ID: 32530761
[TBL] [Abstract][Full Text] [Related]
23. Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany.
Voelkel V; Draeger T; Groothuis-Oudshoorn CGM; de Munck L; Hueting T; Gerken M; Klinkhammer-Schalke M; Lavric M; Siesling S
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1823-1833. PubMed ID: 30927074
[TBL] [Abstract][Full Text] [Related]
24. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
Munsch C; Lauwers-Cances V; Lamant L; Gentil C; Rochaix P; Garrido I; Lopez R; Chevreau C; Paul C; Meyer N
Dermatology; 2014; 229(3):183-9. PubMed ID: 25171688
[TBL] [Abstract][Full Text] [Related]
25. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
26. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
Verver D; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Eggermont AMM; Verhoef C; Grünhagen DJ
Eur J Cancer; 2018 Jun; 96():25-33. PubMed ID: 29660597
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.
El Sharouni MA; Ahmed T; Varey AHR; Elias SG; Witkamp AJ; Sigurdsson V; Suijkerbuijk KPM; van Diest PJ; Scolyer RA; van Gils CH; Thompson JF; Blokx WAM; Lo SN
J Clin Oncol; 2021 Apr; 39(11):1243-1252. PubMed ID: 33600211
[TBL] [Abstract][Full Text] [Related]
28. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
29. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
Hu J; Jiao X; Zhu L; Guo H; Wu Y
BMC Cancer; 2020 Sep; 20(1):938. PubMed ID: 32993522
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
[TBL] [Abstract][Full Text] [Related]
31. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study.
Xiao Y; Peng S; Hu Y; Zhang J; Cao X
Cancer Med; 2020 Nov; 9(22):8562-8570. PubMed ID: 32941704
[TBL] [Abstract][Full Text] [Related]
33. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
34. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
[TBL] [Abstract][Full Text] [Related]
35. Value of sentinel node status as a prognostic factor in melanoma: prospective observational study.
Kettlewell S; Moyes C; Bray C; Soutar D; MacKay A; Byrne D; Shoaib T; Majumder B; MacKie R
BMJ; 2006 Jun; 332(7555):1423. PubMed ID: 16735303
[TBL] [Abstract][Full Text] [Related]
36. Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma.
Kukar M; Gabriel E; May R; Cho E; Lichtenthal M; Groman A; Skitzki J; Francescutti V; Kane JM
Am Surg; 2017 Nov; 83(11):1256-1262. PubMed ID: 29183528
[TBL] [Abstract][Full Text] [Related]
37. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
[TBL] [Abstract][Full Text] [Related]
38. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
Kruit WH;
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
[TBL] [Abstract][Full Text] [Related]
39. Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma.
Pasquali S; Mocellin S; Campana LG; Vecchiato A; Bonandini E; Montesco MC; Santarcangelo S; Zavagno G; Nitti D; Rossi CR
Eur J Surg Oncol; 2011 Aug; 37(8):675-80. PubMed ID: 21683543
[TBL] [Abstract][Full Text] [Related]
40. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
